News Image

ARS Pharmaceuticals Announces neffy® (Epinephrine Nasal Spray) is available on Express Scripts Commercial National Formularies

Provided By GlobeNewswire

Last update: Dec 19, 2024

Inclusion of neffy on Express Scripts commercial formularies was effective November 22, 2024 and expands access to patients and caregivers managing Type 1 Allergic Reactions

Read more at globenewswire.com

ARS PHARMACEUTICALS INC

NASDAQ:SPRY (12/19/2025, 8:16:50 PM)

After market: 10.49 0 (0%)

10.49

+0.67 (+6.82%)



Find more stocks in the Stock Screener

Follow ChartMill for more